MedPath

Comparison of therapeutic effects of prednisolone, acyclovir, and combination of these drugs in Bell´s Palsy

Phase 2
Conditions
Bell's palsy.
Facial palsy
Registration Number
IRCT201109187575N1
Lead Sponsor
Arak University of Medical Sciences,Vice chancellor for research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
180
Inclusion Criteria

Inclusion Criteria:
Patients with Bell´s palsy; Age over 10 years

Exclusion Criteria

More than 7 days have passed since the onset of paralysis; Finding another cause for the paralysis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
House-Brackmann score. Timepoint: Each 15 days. Method of measurement: Calculate House-Brackmann score.
Secondary Outcome Measures
NameTimeMethod
Failure to treatment. Timepoint: The end of month 3. Method of measurement: No reduce of House-Brackmann score.
© Copyright 2025. All Rights Reserved by MedPath